 CAMBRIDGE, England BOSTON--BUSINESS WIRE--Bicycle Therapeutics plc NASDAQ: BCYC, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide Bicycle technology, today announced that management will participate in the following investor conferences in November and December: Jefferies London Healthcare Conference on Friday, November 19, 2021; pre-recorded fireside chat available on demand at 3:00 a.m. ET on Thursday, Novembe 